Snowflake's Q4 Outlook Misses Expectations Despite Strong Q3 Results
Snowflake reports 29% product revenue growth but Q4 operating margin guidance falls short of analyst estimates, raising AI profitability concerns.
NOTRELOAD AI
Salesforce Beats Expectations with Strong AI Tool Growth and Outlook
Salesforce surpasses revenue forecasts with $11.2B guidance, driven by Agentforce AI adoption. Stock jumps 5% as company reports 9,500+ paid AI deals and strong bookings growth.
Archer Aviation Launches 10-Min Electric Air Taxi Network in Miami
Archer Aviation announces plans for an air taxi network in the Miami area, offering 10-20 minute electric flights to skip notorious traffic, transforming regional travel.
Incannex IHL-42X Secures FDA Fast Track for OSA Treatment
Incannex's oral drug (IHL-42X) for serious sleep apnea (OSA) got FDA Fast Track status to speed up its development and potential approval.
Guggenheim Downgrades Black Diamond Therapeutics on Silevertinib Concerns
Guggenheim lowers Black Diamond Therapeutics to Neutral, citing toxicity and durability concerns in silevertinib’s Phase 2 trial and risks to key 2026 catalysts.
Protara Therapeutics Shares Climb on Strong Phase 2 Trial Results for TARA-002
Protara Therapeutics stock jumped after positive Phase 2 interim results showed strong response rates for TARA-002 in non-muscle invasive bladder cancer patients.